FDA approves generic Alzheimer’s disease drug
SILVER SPRING, Md. — The Food and Drug Administration has approved a generic drug for treating Alzheimer’s disease, FDA records showed.
The agency announced the approval of Alvogen’s donepezil hydrochloride, a generic version of Aricept, made by Pfizer and Eisai. The generic drug was approved in the 5 mg and 10 mg strengths.
More than 20 other companies also make generic versions of Aricept. The drug is used to treat mild to moderate Alzheimer’s, as well as severe forms of the disease.
FDA gives tentative approval to Mylan’s generic Crestor
SILVER SPRING, Md. — Mylan has received tentative approval for a generic version of a cholesterol drug made by AstraZeneca, according to Food and Drug Administration records.
The FDA gave the tentative approval to Mylan’s rosuvastatin calcium tablets in the 5 mg, 10 mg, 20 mg and 40 mg strengths. The drug is a generic version of AstraZeneca’s Crestor, which had sales of $5.1 billion in 2012, according to IMS Health.
A tentative approval means that the drug meets the FDA’s conditions for approval, but the agency can’t approve it yet because the patent on the branded has not yet expired. AstraZeneca’s patents on Crestor are set to expire between 2016 and 2022, according to FDA records.
IRI acquires FreshLook Marketing Group to better track fresh food sales
CHICAGO — IRI on Tuesday announced the purchase of FreshLook Marketing Group, a leading supplier of market research information and consulting services to the fresh food industry.
“Our food manufacturer and retailer clients are eager for a total store perspective; fresh [food] products are an important component of many retailers’ footprint and profitability,” stated Andrew Appel, president and CEO of IRI. “The FreshLook acquisition enables IRI to further improve its market leadership in providing the total view of the store which manufacturers and retailers want, integrate the two sets of information more efficiently and provide shopper marketing, analytics and consulting services that impact the whole store.”
Fresh food products account for approximately 20% of all outlet sales, according to FreshLook Marketing Group. They play an increasingly important role in establishing the retailer’s image and competitive positioning among manufacturers. FreshLook Marketing Group provides scanner-based sales, actual retail price and distribution information on these products through its Sales Tracking Service. FreshLook Marketing Group’s reports are based on all-store census data from supermarkets across the United States.
“We are eager to expand our long-term relationship with IRI, enabling us to drive substantially more value for our clients in the fresh categories,” commented Mark Degner, president and CEO FreshLook Marketing Group. “In addition to offering manufacturers and retailers an integrated view of the store, we look forward to expanding our engagement with current FreshLook Marketing clients by offering IRI solutions and services.”
Prior to forming FreshLook Marketing Group in 2000, Degner was an executive at IRI.